SEC Form 4 · accession 0001209191-16-119146
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Mooradian
Officer — Corp VP, Global Ops & Supp Chn
Period of report
Jun 5, 2015
Accepted (ET)
May 11, 2016 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000917520
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 5, 2015 | S | 2,300 | $68.5747 | D | 11,382 | D | |
| Common StockF2 | Oct 16, 2015 | S | 1,200 | $59.3732 | D | 10,182 | D | |
| Common StockF3 | May 9, 2016 | S | 4,153 | $73.1562 | D | 6,029 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $68.5538 to $68.63.
- F2The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $59.3555 to $59.43.
- F3The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $73.06 to $73.27.